Philip Morris International Reports 2023 Third-Quarter and Nine-Month Year-to-Date Results

Delivers 2023 Third-Quarter Reported Diluted EPS of $1.32 and Adjusted Diluted EPS of $1.67, Representing Currency-Neutral Growth of 20.3%; Targets 2023 Full-Year Reported Diluted EPS of $4.95 to...

Related Keywords

Russia ,Taiwan ,Turkey ,Bangladesh ,Australia ,Czech Republic ,Lviv ,L Vivs Ka Oblast ,Ukraine ,Egypt ,Italy ,Pakistan ,Canada ,United Kingdom ,Germany ,Brazil ,Indonesia ,Japan ,Philippines ,Kharkiv ,Kharkivs Ka Oblast ,Poland ,Spain ,Mexico ,Algeria ,China ,South Korea ,Sweden ,Argentina ,France ,Swedish ,Ukrainian ,Russian ,Jacek Olczak ,Vectura Fertin Pharma ,Emmanuel Babeau ,International Market Share ,Philip Morris International ,International Duty Free ,International Share Of Market ,Drug Administration ,Philip Morris International Inc ,Regulatory News ,Morris International ,Product Shipment Volume ,Free Product Net Revenues ,Total Net Revenues ,Diluted Earnings ,Swedish Match ,Chief Executive ,Smoke Free World ,Middle East ,Year Forecast ,Europe Region ,Cautionary Statements ,Chief Financial Officer ,Eastern Time ,Southeast Asia ,Independent States ,Americas Region ,East Asia ,Americas Regions ,Excluding Russia ,Cigarette Market Share ,Ended September ,Research Costs ,Months Ended September ,Net Revenues ,Market Share ,Fertin Pharma ,Operating Income ,Modified Risk Tobacco ,Private Securities Litigation Reform Act ,Quarterly Report ,Total Market ,Markets ,